This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Andrea Challand: Innovator in Cell Analytical Technology
Introduction
Andrea Challand is a notable inventor based in Penzberg, Germany. She has made significant contributions to the field of cell analytical technology, particularly through her innovative patent. Her work focuses on enhancing the understanding of tumor and natural killer cell interactions.
Latest Patents
Andrea Challand holds a patent for the "3D ADCC NK FACS assay." This technology is based on a three-dimensional spheroid or aggregate co-culture assay, which allows for the formation of spheroids or aggregates composed of tumor and natural killer cells. This method is particularly useful for in vitro functional analysis of antibodies in both single and high-throughput formats. The patent showcases her expertise in developing advanced analytical techniques.
Career Highlights
Throughout her career, Andrea has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has contributed to her knowledge and skills in the field of biotechnology and cell analysis.
Collaborations
Andrea has collaborated with esteemed colleagues such as Christian Klein and Manfred Kubbies. These partnerships have likely enriched her research and development efforts, leading to innovative solutions in her area of expertise.
Conclusion
Andrea Challand is a pioneering inventor whose work in cell analytical technology has the potential to advance the understanding of cancer therapies. Her contributions, particularly through her patent, highlight her role as a key figure in the field.